Doximity, Inc.

NYSE DOCS

Doximity, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2024: USD 202.10 M

Doximity, Inc. EBIT is USD 202.10 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 44.03% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Doximity, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 140.32 M, a 27.66% change year over year.
Doximity, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 109.92 M, a 25.95% change year over year.
Doximity, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 87.27 M.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

NYSE: DOCS

Doximity, Inc.

CEO	Mr. Jeffrey A. Tangney
IPO Date	June 24, 2021
Location	United States
Headquarters	500, 3rd Street
Employees	827
Sector	Health Care
Industries Telehealth Medical Instruments

Description

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Key trends

Past 5 years